These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 22945591)

  • 1. Uric acid as a danger signal in gout and its comorbidities.
    Rock KL; Kataoka H; Lai JJ
    Nat Rev Rheumatol; 2013 Jan; 9(1):13-23. PubMed ID: 22945591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gout-associated uric acid crystals activate the NALP3 inflammasome.
    Martinon F; Pétrilli V; Mayor A; Tardivel A; Tschopp J
    Nature; 2006 Mar; 440(7081):237-41. PubMed ID: 16407889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immunological Basis in the Pathogenesis of Gout.
    Chen J; Wu M; Yang J; Wang J; Qiao Y; Li X
    Iran J Immunol; 2017 Jun; 14(2):90-98. PubMed ID: 28630380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions.
    Yang S; Liu H; Fang XM; Yan F; Zhang Y
    Int Immunopharmacol; 2024 May; 132():111932. PubMed ID: 38560961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Cartilage Homogenates Influence the Crystallization of Monosodium Urate and Inflammatory Response to Monosodium Urate Crystals: A Potential Link Between Osteoarthritis and Gout.
    Chhana A; Pool B; Wei Y; Choi A; Gao R; Munro J; Cornish J; Dalbeth N
    Arthritis Rheumatol; 2019 Dec; 71(12):2090-2099. PubMed ID: 31297987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystallization of monosodium urate.
    Martillo MA; Nazzal L; Crittenden DB
    Curr Rheumatol Rep; 2014 Feb; 16(2):400. PubMed ID: 24357445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid, hyperuricemia and vascular diseases.
    Jin M; Yang F; Yang I; Yin Y; Luo JJ; Wang H; Yang XF
    Front Biosci (Landmark Ed); 2012 Jan; 17(2):656-69. PubMed ID: 22201767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the pathological biomineralization of monosodium urate crystals in gout patients.
    Rodriguez-Navarro C; Elert K; Ibañez-Velasco A; Monasterio-Guillot L; Andres M; Sivera F; Pascual E; Ruiz-Agudo E
    Commun Biol; 2024 Jul; 7(1):828. PubMed ID: 38972919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monosodium urate crystals in the knee joints of patients with asymptomatic nontophaceous gout.
    Bomalaski JS; Lluberas G; Schumacher HR
    Arthritis Rheum; 1986 Dec; 29(12):1480-4. PubMed ID: 3801071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout.
    Holzinger D; Nippe N; Vogl T; Marketon K; Mysore V; Weinhage T; Dalbeth N; Pool B; Merriman T; Baeten D; Ives A; Busso N; Foell D; Bas S; Gabay C; Roth J
    Arthritis Rheumatol; 2014 May; 66(5):1327-39. PubMed ID: 24470119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of Macrophage Receptor MARCO, LDL, and LDLR to Disease-Associated Crystalline Structures.
    Alberts A; Klingberg A; Hoffmeister L; Wessig AK; Brand K; Pich A; Neumann K
    Front Immunol; 2020; 11():596103. PubMed ID: 33363539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?
    Ruoff G; Edwards NL
    Postgrad Med; 2016 Sep; 128(7):706-15. PubMed ID: 27558643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals.
    Scott P; Ma H; Viriyakosol S; Terkeltaub R; Liu-Bryan R
    J Immunol; 2006 Nov; 177(9):6370-8. PubMed ID: 17056568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout: a prelude to a new add-on therapy?
    Vazirpanah N; Ottria A; van der Linden M; Wichers CGK; Schuiveling M; van Lochem E; Phipps-Green A; Merriman T; Zimmermann M; Jansen M; Radstake TRDJ; Broen JCA
    Ann Rheum Dis; 2019 May; 78(5):663-671. PubMed ID: 30814053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid-mediated inflammasome activation in IL-6 primed innate immune cells is regulated by baricitinib.
    Temmoku J; Fujita Y; Matsuoka N; Urano T; Furuya MY; Asano T; Sato S; Matsumoto H; Watanabe H; Kozuru H; Yatsuhashi H; Kawakami A; Migita K
    Mod Rheumatol; 2021 Jan; 31(1):270-275. PubMed ID: 32148148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank.
    Sandoval-Plata G; Nakafero G; Chakravorty M; Morgan K; Abhishek A
    Rheumatology (Oxford); 2021 Jul; 60(7):3243-3251. PubMed ID: 33313843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout.
    Liu L; Xue Y; Zhu Y; Xuan D; Yang X; Liang M; Wang J; Zhu X; Zhang J; Zou H
    Arthritis Res Ther; 2016 Nov; 18(1):268. PubMed ID: 27863506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPS8 regulates an NLRP3 inflammasome-independent caspase-1 activation pathway in monosodium urate crystal-treated RAW264.7 macrophages.
    Chuang JP; Kao CY; Lee JC; Ling P; Maa MC; Leu TH
    Biochem Biophys Res Commun; 2020 Sep; 530(3):487-493. PubMed ID: 32595041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients?
    Schreiner O; Wandel E; Himmelsbach F; Galle PR; Märker-Hermann E
    Nephrol Dial Transplant; 2000 May; 15(5):644-9. PubMed ID: 10809805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia and gout.
    Pascual E
    Curr Opin Rheumatol; 1994 Jul; 6(4):454-8. PubMed ID: 8068519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.